Neurology · 2004 · 130 citations · 8 references
MedicineNeurologyPharmacotherapyNeuromuscular DisordersNeuropathologyNeurophysiologyAxonal DegenerationMotor NeuropathyPeripheral Neuropathy ManagementAxonal PolyneuropathyPeripheral Neuropathy Pharmacotherapy
The authors treated 10 patients with multifocal motor neuropathy (MMN) responding to an initial course of IV immunoglobulin (IVIg) with periodic infusion for 5 to 12 years (mean 8.2 years). At last follow-up, only two patients had maintained the maximal improvement achieved during therapy while eight worsened despite increasing Ig dosage. This decline started after 3 to 7 years (mean 4.8 years) of therapy and correlated with a reduction of distal compound muscle action potential amplitudes (p < 0.019). The effectiveness of IVIg in MMN often declines after several years possibly associated with the development of axonal degeneration.
8
Jean‐Marie Léger, B. Chassande, L. Musset et al. · Brain · 2001 · 279 citations · Full text
Medicine, Neurology, Pharmacotherapy +11
Multifocal motor neuropathy improved by IVIg
Piera Federico, Douglas W. Zochodne, Angelika F. Hahn et al. · Neurology · 2000 · 265 citations
Medicine, Neurology, Pharmacotherapy +17
Leonard H. van den Berg, Henk Kerkhoff, P. Liam Oey et al. · Journal of Neurology Neurosurgery & Psychiatry · 1995 · 253 citations · Full text
Renske M. van den Berg‐Vos, Harrie‐Jan Hendricks Franssen, John H. J. Wokke et al. · Brain · 2002 · 168 citations · Full text
Medicine, Neurology, Pharmacotherapy +17